新型冠狀病毒感染懷孕病人用藥考量
陳立奇 - 臺灣臨床藥學雜誌, 2022 - airitilibrary.com
… non-steroidal anti-inflammatory drugs, and thromboprophylactic drugs. Based on current
evidence, most of these might be used safely in pregnant patients with COVID-19. Meanwhile, …
evidence, most of these might be used safely in pregnant patients with COVID-19. Meanwhile, …
[PDF][PDF] 新型冠状病毒肺炎患者的抗血栓治疗研究进展
李健超， 李树仁， 赵文静， 郝潇… - Journal of …, 2021 - boyuancaibian.oss-cn-beijing …
… 本文就COVID-19 患者的抗凝治疗和抗血小板 治疗进行综述,以期为COVID-19 患者的抗血栓…
Despite thromboprophylaxis, thromboembolism is still common and patients with thrombotic …
Despite thromboprophylaxis, thromboembolism is still common and patients with thrombotic …
1 例奈玛特韦/利托那韦联合利伐沙班和胺碘酮致肝损伤及心动过缓的病例分析.
姜静静， 唐原君， 范国荣… - Practical Pharmacy & …, 2023 - search.ebscohost.com
… for thromboprophylaxis in patients with COVID-19 [ J ]. Blood Advꎬ2021ꎬ5(3):872-888. …
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to …
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to …
弥散性血管内凝血的发病机制及药物治疗进展
冯悦， 王静， 李欣欣， 马晓慧， 胡庆华 - 药学进展, 2023 - pps.cpu.edu.cn
… 及产科手 术相关的严重并发症,新型冠状病毒感染(COVID-19)的重症患者亦有相伴发生DIC 的
临床报道.DIC … dose heparins for thromboprophylaxis in high-risk hospitalized patients With …
临床报道.DIC … dose heparins for thromboprophylaxis in high-risk hospitalized patients With …
新型冠状病毒大规模感染期门诊患者常规血液检测指标血栓风险分析.
魏玲， 邵玲俐， 陈婷， 任娟… - China Tropical Medicine, 2023 - search.ebscohost.com
… for optimal thromboprophylaxis in patients with COVID-19: a … for thromboprophylaxis for
patients with COVID-19: March 2022 … and he⁃ matology findings based on the current evidences: …
patients with COVID-19: March 2022 … and he⁃ matology findings based on the current evidences: …
[HTML][HTML] 磺达肝癸钠对COPD, 肺癌, ILD, 老年肺炎患者VTE 干预作用: 多中心, 随机, 对照研究
高靖， 李运成， 耿立梅， 刘宝良， 段炜， 许建英… - Advances in Clinical …, 2022 - hanspub.org
… 国外COVID-19患者VTE预防的相关研究中,有研究表明磺达肝癸钠与低分子肝素间有效性与… 高
[11],这可能与COVID-19对肾脏的侵袭有关,而亚洲人群中COVID-19患者的VTE预防相关研究较少…
[11],这可能与COVID-19对肾脏的侵袭有关,而亚洲人群中COVID-19患者的VTE预防相关研究较少…
新型冠状病毒感染合并静脉血栓栓塞症的临床研究进展——基于当前的循证证据
徐嘉堂， 曹淋， 曾晓莹， 沈润楠， 尤国昌… - 岭南现代临床外科, 2023 - lingnanwaike.com
… combined with venous thromboem⁃ bolism:based on current evidence⁃based evidence …
Thera⁃ peutic versus prophylactic anticoagulation for severe COVID ⁃ 19:A randomized phase …
Thera⁃ peutic versus prophylactic anticoagulation for severe COVID ⁃ 19:A randomized phase …
居家用药环节严重用药错误文献分析.
闫阔， 成晓玲， 杨慧鹃， 夏文斌… - Practical Pharmacy & …, 2023 - search.ebscohost.com
… for thromboprophylaxis in patients with COVID-19 [ J ]. Blood Advꎬ2021ꎬ5(3):872-888. …
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to …
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to …
[PDF][PDF] 神经肌肉电刺激联合间歇性充气加压预防颅脑外伤患者下肢深静脉血栓的临床研究
沈永艳， 范家权， 沈丽， 赵丽… - Progress in Modern …, 2023 - biomed.cnjournals.com
… , and to provide evidence for the selection of intervention measures to prevent LEDVT. …
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 …
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 …
[HTML][HTML] 川崎病冠状动脉病变研究进展
雷丹， 吴晓云 - Advances in Clinical Medicine, 2022 - hanspub.org
: 川崎病(KD) 是一种主要发生于儿童的全身性炎症性疾病. 其常见的并发症是冠状动脉损害. 文章
总结了KD 冠状动脉病变的机制, 危险因素以及治疗进展, 以期为该疾病的诊断, 治疗等提供临床…
总结了KD 冠状动脉病变的机制, 危险因素以及治疗进展, 以期为该疾病的诊断, 治疗等提供临床…